BE474490A - - Google Patents
Info
- Publication number
- BE474490A BE474490A BE474490DA BE474490A BE 474490 A BE474490 A BE 474490A BE 474490D A BE474490D A BE 474490DA BE 474490 A BE474490 A BE 474490A
- Authority
- BE
- Belgium
- Prior art keywords
- virus
- pig
- animal
- swine cholera
- cholera
- Prior art date
Links
- 241000700605 Viruses Species 0.000 claims description 95
- 241000282898 Sus scrofa Species 0.000 claims description 88
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 65
- 241001465754 Metazoa Species 0.000 claims description 55
- 206010008631 Cholera Diseases 0.000 claims description 44
- 238000000034 method Methods 0.000 claims description 28
- 241000282887 Suidae Species 0.000 claims description 21
- 210000000952 spleen Anatomy 0.000 claims description 20
- 208000024891 symptom Diseases 0.000 claims description 13
- 238000004519 manufacturing process Methods 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 11
- 230000008569 process Effects 0.000 claims description 10
- 230000003053 immunization Effects 0.000 claims description 9
- 238000002347 injection Methods 0.000 claims description 9
- 239000007924 injection Substances 0.000 claims description 9
- 229960005486 vaccine Drugs 0.000 claims description 9
- 239000002054 inoculum Substances 0.000 claims description 8
- 230000001018 virulence Effects 0.000 claims description 7
- 230000001575 pathological effect Effects 0.000 claims description 6
- 238000011161 development Methods 0.000 claims description 4
- 230000001681 protective effect Effects 0.000 claims description 4
- 230000035755 proliferation Effects 0.000 claims description 2
- 238000002679 ablation Methods 0.000 claims 1
- 229960005004 cholera vaccine Drugs 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
- 206010037660 Pyrexia Diseases 0.000 description 19
- 210000004369 blood Anatomy 0.000 description 19
- 239000008280 blood Substances 0.000 description 19
- 238000011081 inoculation Methods 0.000 description 15
- 210000002966 serum Anatomy 0.000 description 15
- 201000010099 disease Diseases 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 208000015181 infectious disease Diseases 0.000 description 11
- 239000000725 suspension Substances 0.000 description 8
- 230000002238 attenuated effect Effects 0.000 description 7
- 230000036039 immunity Effects 0.000 description 5
- 238000002649 immunization Methods 0.000 description 5
- 230000000521 hyperimmunizing effect Effects 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 230000000890 antigenic effect Effects 0.000 description 3
- 230000002458 infectious effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 241001494479 Pecora Species 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 244000144980 herd Species 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 238000002255 vaccination Methods 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000710777 Classical swine fever virus Species 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 241000272201 Columbiformes Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000282339 Mustela Species 0.000 description 1
- 241000606860 Pasteurella Species 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000010460 detection of virus Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000004719 natural immunity Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/187—Hog cholera virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE474490A true BE474490A (show.php) |
Family
ID=123480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE474490D BE474490A (show.php) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE474490A (show.php) |
-
0
- BE BE474490D patent/BE474490A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2548115B2 (ja) | トリの抗体を用いた哺乳動物の受動免疫化 | |
| World Health Organization | Cholera vaccines: WHO position paper= Vaccins anticholériques: Note d'information de l'OMS | |
| EP1159968A1 (fr) | Souches atténuées du virus de la Dengue et leur utilisation dans une composition vaccinale | |
| Smith et al. | Cross‐protection studies with gut membrane glycoprotein antigens from Haemonchus contortus and Teladorsagia circumcincta | |
| Shope | Studies on immunity to swine influenza | |
| CA1090701A (fr) | Medicament permettant de traiter les infections aigues ou chroniques dues au virus de l'hepatite b | |
| BE474490A (show.php) | ||
| FR2466251A1 (fr) | Vaccin animal anticolibacillaire, obtention et application | |
| Jungeblut et al. | Isolation of a Murine Neurotropic Virus by Passage of Monkey Poliomyelitis Virus to Cotton Rats and White Mice. | |
| FR2590172A1 (fr) | Nouvel antigene commun (psc-a) de pseudomonas aeruginosa protegeant contre l'infection provoquee par cet organisme | |
| Schwartz | The Pasteurian contribution to the history of vaccines | |
| CH278772A (fr) | Procédé de préparation d'un vaccin contre le choléra du porc possédant une virulence réduite. | |
| Gadebusch | Specific Degradation of Cryptococcus neoformans 3723 Capsular Polysaccharide by a Microbial Enzyme: III. Antibody Stimulation by Partially Decapsulated Cells | |
| EP0051522B1 (fr) | Mutant de septicémie hémorragique virale, vaccin contenant ce mutant et procédé pour sa préparation | |
| JPH01279844A (ja) | Ａ型肝炎ワクチン | |
| FR2714065A1 (fr) | Antigène visant à conférer une immunité protectrice contre les helminthiases chez l'homme et l'animal et procédé de vaccination pour l'application dans l'immunoprophylaxie des helminthiases. | |
| CA2181885A1 (fr) | Solution injectable de fluorure de benzalkonium | |
| Zhang et al. | Booster vaccination with live attenuated Vibrio anguillarum elicits strong protection despite weak specific antibody response in zebrafish | |
| BE624526A (show.php) | ||
| FR2487201A2 (fr) | Preparation lymphocytaires applicables en therapeutique humaine, procede d'obtention et applications | |
| RU2851230C2 (ru) | Вакцины против moritella viscosa | |
| WO1995001805A1 (fr) | Vaccin contre la dysenterie hemorragique du porc et ensemble de vaccination y relatif | |
| mondiale de la Santé et al. | Update on vaccine-derived polioviruses–worldwide, January 2018–June 2019–Le point sur les poliovirus dérivés d’une souche vaccinale dans le monde, janvier 2018-juin 2019 | |
| EP1131094A1 (fr) | Vaccin t.d.polio multivalent contre au moins la diphterie, la poliomyelite et le tetanos | |
| World Health Organization | PRODUCTION AND CONTROL OF VACCINES: WHO informal consultation on WHO requirements for diphtheria, pertussis, tetanus and combined vaccines= PRODUCTION ET CONTRÔLE DES VACCINS: Consultation informelle de l’OMS sur les nonnes OMS relatives aux vaccins antidiphtérique, anticoquelucheux, antitétanique et aux vaccins associés |